APA (7th ed.) Citation

Liu, C., Wang, X., Xu, C., Liu, X., Ke, L., Li, Y., . . . Shi, L. (2025). Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. BMC Neurology, 25(1), 1. https://doi.org/10.1186/s12883-025-04378-z

Chicago Style (17th ed.) Citation

Liu, Chang, et al. "Long-read Sequencing Identifies ATXN3 Repeat Expansions, and Transcriptomics Reveals Disease Progression Biomarkers and Druggable Targets for Spinocerebellar Ataxia Type 3." BMC Neurology 25, no. 1 (2025): 1. https://doi.org/10.1186/s12883-025-04378-z.

MLA (9th ed.) Citation

Liu, Chang, et al. "Long-read Sequencing Identifies ATXN3 Repeat Expansions, and Transcriptomics Reveals Disease Progression Biomarkers and Druggable Targets for Spinocerebellar Ataxia Type 3." BMC Neurology, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12883-025-04378-z.